The FOE Diabetes Research Center Welcomes New Faculty Members

The Fraternal Order of Eagles Diabetes Research Center is pleased to welcome three new faculty members to our research team. Brian O’Neill, Yumi Imai, and Sam Stephens all joined the DRC at the end of the summer.

Brian O’Neill, MD, PhD is an Assistant Professor of Internal Medicine, Division of Endocrinology and Metabolism. He comes to us from the Joslin Diabetes Center/Beth Israel Deaconess Medical Center (BIDMC). He received his degrees from the University of Utah School of Medicine and completed his residency and an Endocrine Fellowship at BIDMC. He trained as a research fellow in the laboratory of C. Ronald Kahn at the Joslin Diabetes Center. Dr. O’Neill’s research interest includes metabolic complications and dysregulation of muscle physiology that occur in obesity and diabetes and the impact of diabetes and insulin resistance on protein turnover and mitochondrial metabolism.

Yumi Imai, MD is an Associate Professor of Internal Medicine, Division of Endocrinology and Metabolism. She comes to us from Eastern Virginia Medical School where she served as the Division Chief of Endocrinology and Metabolism. She received her MD from Tohoku University. She trained in endocrinology and metabolism at the National Institutes of Health and the University of Pennsylvania. Dr. Imai’s research interest includes the modulation of islet cell function by lipids and the role that this plays in beta cell dysfunction in type 2 diabetes.

Sam Stephens, PhD is an Assistant Professor of Internal Medicine, Division of Endocrinology and Metabolism. He comes to us from the Duke Molecular Physiology Institute at Duke University Medical Center. He received his PhD from Duke University, and completed his post-doctoral training in the laboratory of Dr. Christopher Newgard. Dr. Stephens research focuses on novel signaling pathways that regulate beta-cell function and survival. His studies seek to determine if the modulation of these pathways could lead to enhanced beta cell survival in diabetes.

The recruitment of these outstanding faculty members will significantly advance our mission towards prevention, treatment and ultimately a cure for diabetes and its complications.

Date: 
Wednesday, September 28, 2016